MANILA, Philippines — The Food and Drug Administration (FDA) on Thursday said it is targeting to complete by next week its evaluation on the emergency use authorization (EUA) application of Sinopharm for its COVID-19 vaccine.
In a taped meeting with President Rodrigo Duterte aired Thursday, FDA Director General Eric Domingo said data on the Sinopharm jab is now being reviewed by the country’s vaccine expert panel.
“This morning po ang Department of Health nakipagmeeting na po doon sa mga representatives ng Sinopharm. At the same time ang FDA naman kahapon, pinadala na rin po natin sa vaccine expert panel yung mga scientific data at clinical trial data ng bakuna na ito para ka…
Keep on reading: FDA aims to finish evaluation on Sinopharm’s COVID-19 vaccine by next week